Company

illumina France

Genopole Campus 1 – Bâtiment 7
5 rue Henri Auguste Desbruères
91030 EVRY – FRANCE
Phone: +33 805 102 193
Email: ILMN-Org-SolutionsCenterParis@illumina.com

Caroline Thureau, Sr Director, France General Manager.

Web Site >

#Consultancy / Training

High Throughput Sequencing Platforms
Sequencing Solutions
Bioinformatic
Training
Library Preparation

Field of Activity

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

BACKGROUND

April 1998: Illumina Foundation by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee
2001: Start of nucleotide polymorphism (SNP) genotyping service offerings and launch of the first system, the Illumina Bead Array Reader with the Beadlab
January 2007: Acquisition of Solexa and launch of the first new generation high-throughput sequencers (NGS) Description of the

PRODUCTS / SERVICES / TECHNOLOGY

Sequencing platforms: iSeq100, MiniSeq, MiSeq, NextSeq, HiSeq, NovaSeq
Genotyping platforms: BeadLab, iScan
Applications: SBS Technology, Illumina AmpliSeq, TruSeq / TruSight / Nextera Technologies, VeriSeq DPNI Technology
Customer Training
Technical support on customer site Customer references

COLLABORATIONS / HIGHLIGHTS

Establishment at the Genopole in Nov. 2017
First commercial site in continental Europe
World leader in sequencing, 90% of the sequences generated from Illumina platforms
Collaboration with the largest hospitals, research centers and private laboratories in France
Awards: Smartest Company by MIT Technology Review (2014) / Top10 Innovations Companies by The Scientist Magazine (2015)

COLLABORATIONS SOUGHT
Innovations in the fields of sequencing:

Automation,
Library Prep,
Bioinformatics

Further Information

Revenues : 2.75Mds USD (Global) for 2017
Number of patents : 3594 (USA)
Number of employees : France 40+ / Global 7000+
Strenghts:
Global Leading company in the sequencing area A range of sequencers that meet all needs, from iSeq100 to NovaSeq
Innovation:
A broad patent portfolio, exclusive SBS technology, automated CE-IVD solution for NIPT

Genopole’s Companies

#Consultancy / Training

In same field

Selart European University France

Selart European University France est un établissement d’enseignement supérieur privé, certifié Qualiopi pour dispenser des actions de formation de niveaux universitaires et lycée d’un an et des formations professionnelles, en présentiel ou en ligne. Activités de recherche et programmes de mobilité internationale.

Discover